(Q46082663)

19 December 2017

title

The alpha-7 nicotinic receptor partial agonist/5-HT3 antagonist RG3487 enhances cortical and hippocampal dopamine and acetylcholine release (English)

1 reference

19 December 2017

author name string

Mei Huang

1

1 reference

19 December 2017

Anna R Felix

2

1 reference

19 December 2017

Sunoh Kwon

3

1 reference

19 December 2017

David Lowe

4

1 reference

19 December 2017

Tanya Wallace

5

1 reference

19 December 2017

Luca Santarelli

6

1 reference

19 December 2017

Herbert Y Meltzer

7

1 reference

19 December 2017

publication date

7 December 2013

1 reference

19 December 2017

published in

Psychopharmacology

1 reference

19 December 2017

volume

231

1 reference

19 December 2017

issue

10

1 reference

19 December 2017

page(s)

2199-2210

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-013-3373-5

exact match

0 references

cites work

Neuronal nicotinic receptors: a perspective on two decades of drug discovery research

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Transient inactivation of the neonatal ventral hippocampus impairs attentional set-shifting behavior: reversal with an α7 nicotinic agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Regionally and functionally distinct serotonin3 receptors control in vivo dopamine outflow in the rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

GABA(A) receptor antagonists enhance cortical acetylcholine release induced by 5-HT(3) receptor blockade in freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

The genetics of sensory gating deficits in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Molecular targets for treating cognitive dysfunction in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Alpha-7 nicotinic acetylcholine receptor agonists selectively activate limbic regions of the rat forebrain: an effect similar to antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Nicotine and epibatidine alter differently nomifensine-elevated dopamine output in the rat dorsal and ventral striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Functional characterization of mouse alpha4beta2 nicotinic acetylcholine receptors stably expressed in HEK293T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Effects of α7 nicotinic acetylcholine receptor agonists on antipsychotic efficacy in a preclinical mouse model of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Tropisetron improves deficits in auditory P50 suppression in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

The characterization of the effect of locally applied N-methylquipazine, a 5-HT3 receptor agonist, on extracellular dopamine levels in the anterior medial prefrontal cortex in the rat: an in vivo microdialysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Nicotinic receptor subtypes and cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Effects of repeated daily treatments with a 5-HT3 receptor antagonist on dopamine neurotransmission and functional activity of 5-HT3 receptors within the nucleus accumbens of Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Antipsychotic property of a muscarinic receptor agonist in animal models for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

5-Hydroxytryptamine3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Effect of R3487/MEM3454, a novel nicotinic alpha7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

The effects of cholinergic and dopaminergic antagonists on nicotine-induced cerebral neurotransmitter changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Galantamine improves cognition in schizophrenic patients stabilized on risperidone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Locally administered low nicotine-induced neurotransmitter changes in areas of cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Nicotine-induced changes in neurotransmitter levels in brain areas associated with cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

The discovery of 2-fluoro-N-(3-fluoro-4-(5-((4-morpholinobutyl)amino)-1,3,4-oxadiazol-2-yl)phenyl)benzamide, a full agonist of the alpha-7 nicotinic acetylcholine receptor showing efficacy in the novel object recognition model of cognition enhanceme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Identification of a series of 1,3,4-oxadiazol-2-amines as potent alpha-7 agonists with efficacy in the novel object recognition model of cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Nicotine blocks apomorphine-induced disruption of prepulse inhibition of the acoustic startle in rats: possible involvement of central nicotinic alpha7 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain--an in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Differential immediate and sustained memory enhancing effects of alpha7 nicotinic receptor agonists and allosteric modulators in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Discovery of a novel alpha-7 nicotinic acetylcholine receptor agonist series and characterization of the potent, selective, and orally efficacious agonist 5-(4-acetyl[1,4]diazepan-1-yl)pentanoic acid [5-(4-methoxyphenyl)-1H-pyrazol-3-yl] amide (SEN1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3373-5

alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment

21 January 2018

1 reference

12 December 2020

Serotonergic modulation of acetylcholine release from cortex of freely moving rats.

1 reference

12 December 2020

Nicotinic agonist modulation of neurotransmitter levels in the rat frontoparietal cortex.

1 reference

12 December 2020

Pharmacological characterization of nicotine-induced acetylcholine release in the rat hippocampus in vivo: evidence for a permissive dopamine synapse.

1 reference

12 December 2020

Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice

1 reference

12 December 2020

Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.

1 reference

12 December 2020

Local alpha-bungarotoxin-sensitive nicotinic receptors in the nucleus accumbens modulate nicotine-stimulated dopamine secretion in vivo

1 reference

12 December 2020

10.1007/S00213-013-3373-5

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

24317442

1 reference

19 December 2017